Personalized Proteomics: The Future of Precision Medicine
AbstractMedical diagnostics and treatment has advanced from a one size fits all science to treatment of the patient as a unique individual. Currently, this is limited solely to genetic analysis. However, epigenetic, transcriptional, proteomic, posttranslational modifications, metabolic, and environmental factors influence a patient’s response to disease and treatment. As more analytical and diagnostic techniques are incorporated into medical practice, the personalized medicine initiative transitions to precision medicine giving a holistic view of the patient’s condition. The high accuracy and sensitivity of mass spectrometric analysis of proteomes is well suited for the incorporation of proteomics into precision medicine. This review begins with an overview of the advance to precision medicine and the current state of the art in technology and instrumentation for mass spectrometry analysis. Thereafter, it focuses on the benefits and potential uses for personalized proteomic analysis in the diagnostic and treatment of individual patients. In conclusion, it calls for a synthesis between basic science and clinical researchers with practicing clinicians to design proteomic studies to generate meaningful and applicable translational medicine. As clinical proteomics is just beginning to come out of its infancy, this overview is provided for the new initiate. View Full-Text
Share & Cite This Article
Duarte, T.T.; Spencer, C.T. Personalized Proteomics: The Future of Precision Medicine. Proteomes 2016, 4, 29.
Duarte TT, Spencer CT. Personalized Proteomics: The Future of Precision Medicine. Proteomes. 2016; 4(4):29.Chicago/Turabian Style
Duarte, Trevor T.; Spencer, Charles T. 2016. "Personalized Proteomics: The Future of Precision Medicine." Proteomes 4, no. 4: 29.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.